Earnings Call · Q1 FY2026·2026-05-05

Q1 26EPS +18.75%·Rev n/aQ4 25EPS +50.00%·Rev n/aQ3 25EPS +6.25%·Rev n/aQ2 25EPS +29.17%·Rev n/a⚠ consensus missing

Adaptive Biotechnologies Corp ADPT

Karina Calzadilla — Investor Relations

Chad M. Robins — CEO and Chairman

Kyle Piskel — Chief Financial Officer

−5.0%1d on move date−5.8% vs SPY3d+1.3%5d−6.6%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more ADPT calls or request research access.

More ADPT calls Browse calls Request research access